Skip to the page

Data / Form D filings / ImCare Biotech, Inc.

ImCare Biotech, Inc.: Form D filings

ImCare Biotech, Inc., a biotechnology company in Doylestown, PA, filed 5 Form D notices with the SEC between 2020 and 2023. The latest, on July 14, 2023, reports $153,402 sold of a $153,402 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3805 OLD EASTON ROAD, Doylestown, PA, 18902
Phone
1-267-895-1773
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Pennsylvania
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1806270

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2023New notice$153,402$153,4021Jul 5, 2023sec.gov
Apr 13, 2022New notice$368,415$368,4151Apr 6, 2022sec.gov
Jul 27, 2021New notice$1,278,351$1,278,3511Jul 15, 2021sec.gov
May 4, 2021New notice$1,777,419$1,777,4194Apr 20, 2021sec.gov
Mar 12, 2020New notice$680,150$680,1503Mar 5, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Frank Y. FischerDirector
Matthew Y. LeeDirector
Aaron LuExecutive Officer, Director
Xuanyong Lu, PhDExecutive Officer, Director
Felix Y. LuExecutive Officer, Director

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Jul 10, 2023 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ImCare Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.